Overview
Single center, double-blind, randomized, controlled trial in patients who present to the emergency department (ED) with a chief complaint of back pain. A total of 150 patients age 18-65 presenting to the emergency department with chief complaint of backpain will be enrolled from April 2024 - April 2025. Patients will be randomized and symptom levels will be recorded at 30, 60, 90, minutes. Follow-up will be performed by telephone at 24 hours.
Eligibility
Inclusion Criteria:
- Age 18 - 65 years old
- Presenting to the Bronson ED with a chief complaint of acute, non-traumatic back pain
- VAS score >5 cm
Exclusion Criteria:
- Back pain due to traumatic injury
- Experiencing saddle anesthesia
- Has bowel or bladder dysfunction
- Has an abnormal neurological exam
- Requires imaging in ED
- Has a Glascow coma score <15
- Has one or more abnormal vital signs:
HR>120, SBP>180 or <90, temperature >38°, O2 saturation<92%
- Has an allergy to ketorolac or haloperidol
- Has a known diagnosis of Lewy Body Dementia
- Has a known diagnosis of glaucoma.
- Is known to be pregnant or breastfeeding
- Is a prisoner or ward of the state
- Is unable to consent for themselves/ non-english speaking
- In the opinion of the attending physician or investigator the patient should not participate in the research